A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)
Status:
Terminated
Trial end date:
2021-03-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess safety and clinical efficacy of rivaroxaban in people
with mild Coronavirus Disease 2019 who are at increased risk of disease progression.